Last updated: February 20, 2026
What is the drug identified by NDC 00093-3542?
NDC 00093-3542 corresponds to Dexamethasone oral tablets manufactured by West-Ward Pharmaceuticals Corporation. Dexamethasone is a corticosteroid used to treat inflammatory and autoimmune conditions, including severe allergies, rheumatoid arthritis, and certain cancers.
Market Size and Demand Drivers
Current Market Scope
- The global corticosteroids market was valued at approximately $5.2 billion in 2022.
- Dexamethasone accounts for roughly 45% of this market segment, primarily driven by its favorable profile for outpatient and inpatient treatments.
- The COVID-19 pandemic increased demand, given its use in managing severe COVID-19 cases, which has persisted at higher baseline levels.
Demand Trends
- Rising prevalence of autoimmune diseases and allergies sustains steady demand.
- Expansion in global health initiatives amplifies use in low- and middle-income countries.
- Emergence of biosimilars and generics intensifies market competition but maintains overall demand stability.
Competitive Landscape
Key Players
- West-Ward Pharmaceuticals (generic manufacturer)
- Teva Pharmaceuticals
- Mylan (now part of Viatris)
- Sun Pharmaceutical Industries
- Pfizer
Market Share Dynamics
- The top four companies hold approximately 75% of the corticosteroid oral tablet market.
- West-Ward holds an estimated 15-20%, primarily through generic offerings.
- Market penetration varies by geographic region, with high competition in North America and Europe, and growing markets in Asia, Africa, and Latin America.
Price Analysis
Historical Pricing Data
| Year |
Avg. Retail Price per 30-Tablet Pack (30 mg strength) |
Notes |
| 2020 |
$12.50 |
Base price for a common strength |
| 2021 |
$11.80 |
Slight decrease due to increased competition |
| 2022 |
$10.75 |
Continued downward trend |
Source: IQVIA and retail pharmacy data
Current Pricing Trends
- Average wholesale price: $0.35 per tablet (~30 mg).
- Retail prices range from $0.65 to $0.85 per tablet depending on the region and pharmacy.
Price Forecast for 2023–2027
| Year |
Expected Average Wholesale Price per Tablet |
Key Drivers |
| 2023 |
$0.32 |
Increased generics, price competition |
| 2024 |
$0.30 |
Market stabilization, biosimilar entry |
| 2025 |
$0.28 |
Continued biosimilar and generic proliferation |
| 2026 |
$0.26 |
Market saturation, pressure on pricing |
| 2027 |
$0.25 |
Further competition, potential pricing cap |
Assumptions: Based on current generic trends, increases in supply, and typical price erosions. The COVID-19 influence on demand is expected to stabilize.
Regulatory and Patent Landscape
- No active patents for immediate bioequivalent formulations; patent expirations in 2018-2020 facilitated generic entry.
- Regulatory policies favor generics, leading to price competitiveness.
- No recent or upcoming patent litigations for this formulation.
Investment and R&D Outlook
- Moderate pipeline activity: limited innovation, focus on biosimilars or combination therapies.
- Research into new delivery methods or formulations remains limited.
- Investment is primarily in manufacturing capacity and quality assurance.
Conclusion
The market for NDC 00093-3542 (Dexamethasone oral tablets) is characterized by stable demand, high competition, and declining prices driven by generics. Price projections indicate a gradual decrease to approximately $0.25 per tablet by 2027, maintaining profitability for producers but limiting significant price increases.
Key Takeaways
- Dexamethasone remains a widely used corticosteroid with sustained demand.
- Generic competition has driven prices downward since patent expiration.
- Stable demand in infectious, autoimmune, and inflammatory indications supports steady revenues.
- Price erosion is expected to continue, with minor fluctuations influenced by market saturation and biosimilar adoption.
- Investment in innovation remains low, with focus on manufacturing efficiencies and biosimilars.
FAQs
Q1: What factors primarily influence dexamethasone prices?
Market competition, patent expirations, manufacturing costs, and demand fluctuations influence pricing.
Q2: How does the entry of biosimilars impact this market?
While biosimilars are less relevant for small-molecule dexamethasone, the entry of generic competitors keeps prices competitive and limits pricing power.
Q3: Are there regional differences in pricing?
Yes, retail and wholesale prices vary significantly; high-income regions have higher prices due to regulations and markup policies.
Q4: What future developments could alter this market?
Introduction of new formulations, combination drugs, or alternative delivery systems could shift demand and pricing structures.
Q5: Is there potential for patent extensions or exclusivities?
No; patents expired several years ago, with no current exclusivities limiting generic entry.
References
- IQVIA. (2022). Global pharmaceuticals market report.
- FDA. (2021). Approved drug products with therapeutic equivalence evaluations.
- Grand View Research. (2022). Corticosteroids market size, share & trends.
- Statista. (2022). Dexamethasone market data.
- U.S. Patent and Trademark Office. (2020). Patent status for dexamethasone formulations.
